Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of mitochondrial solute carrier family 25 (SLC25) identifies member 19 (SLC25A19) as a regulatory factor in hepatocellular carcinoma

30 Jan 2025

Abstract excerpt

• SLC25-based subtypes stratify HCC prognosis. • Triple-gene (SLC25A19/49/51) model predicts HCC outcome. • Single-cell sequencing identifies SLC25A19 as independent HCC prognostic marker. • SLC25A19 drives HCC growth via Wnt pathway. The mitochondrial solute carrier family 25 (SLC25) is known to play a pivotal role in oncogenesis, yet its specific involvement in hepatocellular carcinoma (HCC) remains poorly...

Topics

Join the communities discussing this publication.

Ferroptosis and cancer prognosis
GDF15 and Related Biomarkers
Mitochondrial Function and Pathology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39892835
DOI: 10.1016/j.gene.2025.149299

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of mitochondrial solute carrier family 25 (SLC25) identifies member 19 (SLC25A19) as a regulatory factor in hepatocellular carcinomaPMID 39892835Read ↗

An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesisSemantic proximity Read ↗

Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) in Pan-CancerSemantic proximity Read ↗

Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan‐CancerSemantic proximity Read ↗

SLC35G2 as a Prognostic Biomarker in Hepatocellular carcinoma and Its Correlation with ImmunitySemantic proximity Read ↗

ZNF251 is a novel prognostic biomarker and correlated with the immunosuppressive microenvironment in hepatocellular carcinomaSemantic proximity Read ↗

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerSemantic proximity Read ↗

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerSemantic proximity Read ↗

Role of FBXL19-AS1 in hepatocellular carcinoma by lncRNA–miRNA–mRNA network analysis and its diagnostic and prognostic valueSemantic proximity Read ↗

Comprehensive Analysis of METTLs (METTL1/13/18/21A/23/25/2A/2B/5/6/9) and Associated mRNA Risk Signature in Hepatocellular Carcinoma.Semantic proximity Read ↗

Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer.Semantic proximity Read ↗

Integrated machine learning screened glutamine metabolism-associated biomarker SLC1A5 to predict immunotherapy response in hepatocellular carcinomaSemantic proximity Read ↗

Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.